These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
521 related items for PubMed ID: 16361640
1. Targeting the cell cycle: a new approach to cancer therapy. Schwartz GK, Shah MA. J Clin Oncol; 2005 Dec 20; 23(36):9408-21. PubMed ID: 16361640 [Abstract] [Full Text] [Related]
2. Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy. Schwartz GK. J Clin Oncol; 2005 Jul 10; 23(20):4499-508. PubMed ID: 16002840 [Abstract] [Full Text] [Related]
3. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells. Ahn MY, Lee J, Na YJ, Choi WS, Lee BM, Kang KW, Kim HS. Chem Biol Interact; 2009 May 15; 179(2-3):169-77. PubMed ID: 19070610 [Abstract] [Full Text] [Related]
4. Cyclins and related kinases in cancer cells. Malumbres M. J BUON; 2007 Sep 15; 12 Suppl 1():S45-52. PubMed ID: 17935277 [Abstract] [Full Text] [Related]
5. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs. Potter AJ, Rabinovitch PS. Mutat Res; 2005 May 02; 572(1-2):27-44. PubMed ID: 15790488 [Abstract] [Full Text] [Related]
6. Review: potential role of cell cycle synchronizing agents in combination treatment modalities of malignant tumors. Zalatnai A. In Vivo; 2005 May 02; 19(1):85-91. PubMed ID: 15796159 [Abstract] [Full Text] [Related]
7. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy. Ashwell S, Zabludoff S. Clin Cancer Res; 2008 Jul 01; 14(13):4032-7. PubMed ID: 18593978 [Abstract] [Full Text] [Related]
8. The role of cyclin-dependent kinases in apoptosis. Borgne A, Golsteyn RM. Prog Cell Cycle Res; 2003 Jul 01; 5():453-9. PubMed ID: 14593740 [Abstract] [Full Text] [Related]
9. Cell-cycle control in the face of damage--a matter of life or death. Clarke PR, Allan LA. Trends Cell Biol; 2009 Mar 01; 19(3):89-98. PubMed ID: 19168356 [Abstract] [Full Text] [Related]
10. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M. Drug Resist Updat; 2007 Mar 01; 10(1-2):13-29. PubMed ID: 17303468 [Abstract] [Full Text] [Related]
11. Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy. Senderowicz AM. Cancer Chemother Biol Response Modif; 2001 Mar 01; 19():165-88. PubMed ID: 11686013 [Abstract] [Full Text] [Related]
12. Targeting cell cycle and apoptosis for the treatment of human malignancies. Senderowicz AM. Curr Opin Cell Biol; 2004 Dec 01; 16(6):670-8. PubMed ID: 15530779 [Abstract] [Full Text] [Related]
13. CDK inhibitors in cancer therapy: what is next? Malumbres M, Pevarello P, Barbacid M, Bischoff JR. Trends Pharmacol Sci; 2008 Jan 01; 29(1):16-21. PubMed ID: 18054800 [Abstract] [Full Text] [Related]
14. A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells? O'Connor PM, Kohn KW. Semin Cancer Biol; 1992 Dec 01; 3(6):409-16. PubMed ID: 1286161 [Abstract] [Full Text] [Related]
15. The Ets transcription factor GABP is required for cell-cycle progression. Yang ZF, Mott S, Rosmarin AG. Nat Cell Biol; 2007 Mar 01; 9(3):339-46. PubMed ID: 17277770 [Abstract] [Full Text] [Related]
16. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Lee SJ, Cho YH, Park K, Kim EJ, Jung KH, Park SS, Kim WJ, Moon SK. Biochem Pharmacol; 2008 Jun 15; 75(12):2289-300. PubMed ID: 18468578 [Abstract] [Full Text] [Related]
17. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145. Yun JM, Kweon MH, Kwon H, Hwang JK, Mukhtar H. Carcinogenesis; 2006 Jul 15; 27(7):1454-64. PubMed ID: 16497706 [Abstract] [Full Text] [Related]
18. Effects of carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone on the growth inhibition in human pulmonary adenocarcinoma Calu-6 cells. Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH. Toxicology; 2009 Nov 30; 265(3):101-7. PubMed ID: 19819288 [Abstract] [Full Text] [Related]
19. [Cell cycle-targeted therapy]. Ree AH. Tidsskr Nor Laegeforen; 2004 Oct 07; 124(19):2479-82. PubMed ID: 15477884 [Abstract] [Full Text] [Related]
20. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs. Verheul HM, Qian DZ, Carducci MA, Pili R. Cancer Chemother Pharmacol; 2007 Aug 07; 60(3):329-39. PubMed ID: 17256134 [Abstract] [Full Text] [Related] Page: [Next] [New Search]